Supporting the KCL Health Faculties with creating culture and literacy around research impact.• Supporting the King's Faculties of Life Sciences and Medicine and Dentistry, Oral and Craniofacial Sciences Faculties with research culture, literacy and demonstrating societal impact, with a specific focus on the UK National Research Excellence Framework (REF) exercise.• Signposting and disseminating best practices to plan, generate, evaluate and evidence societal/non-academic impact for research projects, including the creation of tools and delivering training as required.• Developing evidence-driven systems and processes to identify and monitor potential impact case studies in order to highlight, showcase, and celebrate research impact for REF and other impact exercises.• Supporting the development of College-wide systems and processes to evidence King's public and community engagement activity for the national Knowledge Exchange Framework [KEF] exercise.• Creating and supporting processes to mitigate barriers and implement knowledge exchange (including commercialisation, partnerships, policy engagement, and public engagement) and impact strategies at both a Faculty and University-wide level.

• Lead a working group to reform the College Research Misconduct Procedure• Review and update College guidance on patient and public involvement and ethical clearance• Support the development of College guidance on research impact and ethical clearance

Stargardt’s Connected fundraises, runs events and activities for the Stargardt’s community, and raises awareness of Stargardt disease.• Stargardt’s Connected (Registered Charity Number: 1183570) exists to raise awareness, give support and do what we can to progress towards a cure for Stargardt’s disease, a rare form of inherited central vision loss.• We are here to provide information to families affected by Stargardt’s, signpost them to available support, inform about the latest research, and promote a Stargardt’s community that we hope will assist in driving essential research forward. • Although there is no current treatment for Stargardt’s, the continuous groundbreaking research undertaken in the form of drug, gene and stem cell therapies means that treatments for Stargardt’s are looking increasingly optimistic. But there is still a considerable lack of awareness, funds and support for the Stargardt’s community, and this must change.• Stargardt’s Connected is a member of Genetic Alliance UK.

Coordinating the engagement and involvement of patients, public and communities with the national delivery of/participation in health and care research.•Deputy to the Head of Public Engagement, with line management responsibilities within a national matrix team of nine; and supporting engagement leads’ performance across 15 regional hubs.•Coordinating a national programme of public and community engagement projects worth ~£90,000/year; including managing the transformation of the annual Participant in Research Experience Survey to a nationally standardised model with a >200% response increase in year one.•Managing the development of a national impact framework collecting quantitative and qualitative insights to support a shared learning and improvement culture and impact reporting to internal and external stakeholders, including UK Government and the public.•Strategic counsel to senior leaders within NIHR and with external partners including membership on the NIHR Public Partnerships Programme Board and NHS England Increasing Diversity in Research Multi-agency Reference Group. Responsible for achieving business case sign-off and overseeing setup of a first national public advisory group to the CRN Executive Team.•Led delivery of a COVID public engagement programme establishing a network of 50 public advisors to inform the CRN pandemic response including a review process for badging of urgent public health research, and production of a COVID research awareness course on FutureLearn achieving 2655 enrolments in six months, one-fifth of which completed 90% of the course.

PPI Lead for a phase 2a RCT of a new treatment for lazy eye in children aged 3-8 years.• Led the delivery of patient involvement activity to inform the design of this phase 2a randomised controlled feasibility trial.• Co-applicant and author for trial funding applications.• Study Management Group Member.• Point-of-contact for the public representative to the study Steering Committee.• Co-authored BMJ Open publication on the study protocol.• Led analysis of participant experience of participating in the study and co-authored the upcoming publication on the trial results (in process).

Facilitating engagement between patients and researchers to put patient voice at the heart of research strategy and culture.• Team lead and line manager for the BRC PPIE Manager, PPIE Officer and Communications Manager. Co-Chair of the NIHR BRC Public Involvement Leads National Community of Practice.• Led the development and implementation of a first five-year £100,000 public and patient involvement and engagement strategy to drive culture change and embed best practices in public engagement, patient involvement and co-production across Moorfields Eye Hospital and the UCL Institute of Ophthalmology.• Managed annual reporting to NIHR of impact and learning from public engagement and involvement activity and culture building, and reporting on the BRC research portfolio and grants income.• Provided PPIE strategic counsel for the Advancing Clinical Trials In Vision & Eyes (ACTIVE) group advising and training researchers on PPI best practices, and facilitating workshops and focus groups to capture public insights to inform the design and delivery of research studies.• Supported researchers with the engagement with public and patient communities by facilitating disease-specific patient information days using mixed methods to drive public discourse, and through the creation of a public engagement committee with early career researchers and students to drive local culture change around public engagement at the UCL Institute of Ophthalmology.• Led collaboration with Co-Production Collective to pilot a £5,000 co-production funding scheme, resulting in the creation of a new Generation R young people's advisory group for vision research - Eye-YPAG.• Presented at several international vision conferences on patient voice, including ESLRR 2015, ARVO 2017 and 2019 and WAEH 2019; I have also co-authored or contributed to several articles and peer-reviewed publications.

Raising awareness of the progress and potential benefits of research into advanced therapy medicinal products with people living with inherited sight loss conditions.• Managed external communications for two world-first clinical trials of gene & and cell therapies for inherited eye disorders and for a wider portfolio of research into gene and cell therapies, disease mechanisms, and diagnostics.• Supported staff and students working in clinical and discovery research with grant writing and reporting to funders with a focus on pathways to impact and knowledge exchange with public audiences.• Managed a £30,000 Wellcome Trust People Award (#100847) to design and deliver an interactive public information day series - won a UCL Faculty of Brain Sciences Communications Excellence Award.• Managed daily interactions with the public on emerging updates into gene and cell therapies for sight loss and vision, including responding to public enquiries by phone and email and developing newsletters and articles for charity publications.• Led the development of a new group website with a focus on showcasing significant findings and demonstrating the impact of clinical and discovery research on science and society.• Sat on the Public Engagement Committee for the School of Life and Medical Sciences, and co-founded a Community of Practice for sharing and skills development in public engagement for staff and students.• Managed the development of communications and branding for a spin-out gene therapy research company partnering with the commercialisation team at UCL Business.

Strategic counsel to international pharma and life sciences clients, managing a portfolio of clinical trials, drugs, devices, and internal and corporate communications programmes.• Day-to-day point-of-contact to an international pharma client base managing a £0.5 million portfolio of work, including budget allocation and phasing; staff resourcing; timeline development and invoicing.• Led development, content creation and evaluation for press office, direct-to-public health awareness programmes, medical education programmes, internal and corporate communications, and issues management activities.• Counselled clients on emerging communications needs, including issues management, and developed strategies for communication with regulators, government, investors, the media, scientific audiences, and the public. • New business development, including fostering new relationships, interpreting briefs, and contributing to devising creative campaigns and pitching these to existing and potential clients.• Line management and matrix management of project teams.

• Press office - writing press releases; developing collateral for media activity; organising interviews; pitching stories to the media; coverage and KPI reporting.• Medical writing - working with researchers and clinicians to develop content for presentations and videos for medical education programmes and symposia; attending conferences and meetings to develop competitor intelligence reports.

• Project and logistics management – note-taking and meeting minutes; development of project Gantt charts and managing timelines; on and off-site coordination of project logistics, including managing external suppliers.• Consumer health awareness campaigns - rooted in real-life patient case studies - developed content for print, online, TV, radio and social media to raise the public profile of health-related issues, diagnosis, management and impact on quality of life.• Medical writing - working with researchers and clinicians to develop content for presentations and videos for medical education programmes and symposia; attending conferences and meetings to develop competitor intelligence reports.• Press office - writing press releases; developing collateral for media activity; organising interviews; pitching stories to the media; coverage and KPI reporting.

• Completed a dedicated nine-month training programme providing practical training in communications as well as opportunities to learn from leading industry experts alongside PR account work.

• Designed and executed tutorials; facilitated practical demonstrations; marked course work assignments.